Home Healthcare Market Research Report – Forecast to 2027

ホームヘルスケア市場調査レポート、製品別(治療製品、その他)、サービス(熟練看護サービス、呼吸療法サービス、その他)、ソフトウェア(臨床管理システム、遠隔医療ソリューション、その他)-2027年までの予測

ID: MRFR/MED/1498-CR | February 2021 | Region: Global | 85 Pages         

1 Executive Summary

2 Market Introduction

2.1 Definition 18

2.2 Scope Of The Study 18

2.3 List Of Assumptions 19

2.4 Market Structure 19

2.5 Key Takeaways 20

2.6 Key Buying Criteria 20

3 Research Methodology

3.1 Primary Research Methodology 22

3.2 Secondary Research Methodology 23

3.3 Market Share Analysis 23

3.4 Trade Analysis 23

3.5 Market Pricing Approach 24

4 Market Impact Analysis

4.1 Porter’s Five Force Analysis 26

4.1.1 Bargaining Power Of Buyer 27

4.1.2 Bargaining Power Of Supplier 27

4.1.3 Threat From Substitute 27

4.1.4 Threat From A New Entrant 27

4.1.5 Intensity Of Competitive Rivalry 28

4.2 Value Chain Analysis 28

4.2.1 Device Manufacturers 28

4.2.2 App Developers 28

4.2.3 Network Providers/ Mobile Operators 29

4.2.4 Healthcare Providers And Pharmaceuticals 29

4.2.5 Patients 29

4.3 Pricing Analysis 29

4.3.1 Cost-Effectiveness And Patients’ Convenience Will Drive The Home Healthcare Market 29

4.4 Investment Opportunity Analysis 30

4.4.1 Continuous Increase In Lifestyle Disease Has Led To The Development Of Personalized Healthcare Solutions 30

5 Market Dynamics

5.1 Introduction 32

5.2 Drivers 33

5.2.1 Growing Geriatric Population 33

5.2.2 Rising Treatment Cost And Hospital Stay 34

5.2.3 Technological Advancements 35

5.3 Restraints 36

5.3.1 Patients Safety Concerns 36

5.4 Opportunities 37

5.4.1 Rising Prevalence Of Chronic Disorders 37

5.4.2 Improvement In Reimbursement Scenario 38

5.5 Mega Trends 39

5.5.1 Telemedicine 39

5.6 Macroeconomic Indicators 39

5.7 Technology Trends & Assessment 39

6 Global Home Healthcare Market By Product

6.1 Introduction 41

6.1.1 Testing, Screening, & Monitoring Products 42

6.1.2 Therapeutic Products 43

7 Global Home Healthcare Market By Services

7.1 Introduction 45

7.1.1 Skilled Nursing Services 46

7.1.2 Rehabilitation Therapy Services 46

7.1.3 Unskilled Care Services 46

7.1.4 Respiratory Therapy Services 47

7.1.5 Infusion Therapy Services 47

7.1.6 Pregnancy Care Services 48

8 Global Home Healthcare Market By Software

8.1 Introduction 50

8.1.1 Clinical Management Systems 51

8.1.2 Agency Software 51

8.1.3 Telehealth Solution 51

8.1.4 Hospice Solutions 52

9 Global Home Healthcare Market By Region

9.1 Introduction 54

9.2 Americas 55

9.2.1 North America 59

9.2.2 South America 65

9.3 Europe 68

9.3.1 Western Europe 72

9.3.2 Eastern Europe 87

9.4 Asia Pacific 90

9.4.1 Japan 94

9.4.2 China 96

9.4.3 India 98

9.4.4 Republic Of Korea 100

9.4.5 Australia 102

9.4.6 Rest Of Asia-Pacific 104

9.5 Middle East & Africa 107

9.5.1 United Arab Emirates 110

9.5.2 Saudi Arabia 112

9.5.3 Oman 114

9.5.4 Kuwait 116

9.5.5 Qatar 118

9.5.6 Rest Of Middle East & Africa 120

10 Company Landscape

10.1 Competitive Landscape 124

10.2 Company Analysis 124

10.3 Company Market Share 124

11 Company Profiles

11.1 Abbott 126

11.1.1 Financials 126

11.1.2 Products 126

11.1.3 Strategy 126

11.1.4 Key Developments 126

11.2 GE Healthcare 127

11.2.1 Financials 127

11.2.2 Products 127

11.2.3 Strategy 127

11.2.4 Key Developments 127

11.3 Becton Dickinson 128

11.3.1 Financials 128

11.3.2 Products 128

11.3.3 Strategy 128

11.3.4 Key Developments 128

11.4 Omron Corporation 129

11.4.1 Financials 129

11.4.2 Products 129

11.4.3 Strategy 129

11.4.4 Key Developments 129

11.5 Apple 130

11.5.1 Financials 130

11.5.2 Products 130

11.5.3 Strategy 130

11.5.4 Key Developments 130

11.6 Medtronic PLC 131

11.6.1 Financials 131

11.6.2 Products 131

11.6.3 Strategy 131

11.6.4 Key Developments 131

11.7 Koninklijke Philips N.V. 132

11.7.1 Financials 132

11.7.2 Products 132

11.7.3 Strategy 132

11.7.4 Key Developments 132

11.8 LG Electronics 133

11.8.1 Financials 133

11.8.2 Products 133

11.8.3 Strategy 133

11.8.4 Key Developments 133

11.9 Fresenius SE & Co KGaA 134

11.9.1 Financials 134

11.9.2 Products 134

11.9.3 Strategy 134

11.9.4 Key Developments 134

11.10 McKesson Corporation 135

11.10.1 Financials 135

11.10.2 Products 135

11.10.3 Strategy 135

11.10.4 Key Developments 135

11.11 F. Hoffmann-La Roche AG 136

11.11.1 Financials 136

11.11.2 Products 136

11.11.3 Strategy 136

11.11.4 Key Developments 136

11.12 B. Braun Melsungen AG 137

11.12.1 Financials 137

11.12.2 Products 137

11.12.3 Strategy 137

11.12.4 Key Developments 137

11.13 3M 138

11.13.1 Financials 138

11.13.2 Products 138

11.13.3 Strategy 138

11.13.4 Key Developments 138

11.14 A&D Company 139

11.14.1 Financials 139

11.14.2 Products 139

11.14.3 Strategy 139

11.14.4 Key Developments 139

11.15 Kinnser Software 140

11.15.1 Financials 140

11.15.2 Products 140

11.15.3 Strategy 140

11.15.4 Key Developments 140

12 Conclusion 141

12.1 Key Findings 142

12.1.1 From CEO’s View Point 142

13 Appendix 143

13.1 Discussion Blue Print 144

12 List Of Tables

TABLE 1 MARKET SYNOPSIS 16

TABLE 2 LIST OF ASSUMPTIONS 19

TABLE 3 PRIMARY INTERVIEWS 22

TABLE 4 GLOBAL HOME HEALTHCARE MARKET, BY PRODUCT 2020-2027 (USD MILLION) 41

TABLE 5 GLOBAL HOME HEALTHCARE MARKET, BY REGION 2020-2027 (USD MILLION) 42

TABLE 6 GLOBAL HOME HEALTHCARE MARKET, BY TESTING, SCREENING, & MONITORING PRODUCTS 2020-2027 (USD MILLION) 42

TABLE 7 GLOBAL HOME HEALTHCARE MARKET, BY REGION 2020-2027 (USD MILLION) 43

TABLE 8 GLOBAL HOME HEALTHCARE MARKET, BY TESTING, SCREENING, & MONITORING PRODUCTS 2020-2027 (USD MILLION) 43

TABLE 9 GLOBAL HOME HEALTHCARE MARKET, BY SERVICES 2020-2027 (USD MILLION) 45

TABLE 10 GLOBAL HOME HEALTHCARE MARKET, BY REGION 2020-2027 (USD MILLION) 46

TABLE 11 GLOBAL HOME HEALTHCARE MARKET, BY REGION 2020-2027 (USD MILLION) 46

TABLE 12 GLOBAL HOME HEALTHCARE MARKET, BY REGION 2020-2027 (USD MILLION) 46

TABLE 13 GLOBAL HOME HEALTHCARE MARKET, BY REGION 2020-2027 (USD MILLION) 47

TABLE 14 GLOBAL HOME HEALTHCARE MARKET, BY REGION 2020-2027 (USD MILLION) 47

TABLE 15 GLOBAL HOME HEALTHCARE MARKET, BY REGION 2020-2027 (USD MILLION) 48

TABLE 16 GLOBAL HOME HEALTHCARE MARKET, BY SOFTWARE 2020-2027 (USD MILLION) 50

TABLE 17 GLOBAL HOME HEALTHCARE MARKET, BY REGION 2020-2027 (USD MILLION) 51

TABLE 18 GLOBAL HOME HEALTHCARE MARKET, BY REGION 2020-2027 (USD MILLION) 51

TABLE 19 GLOBAL HOME HEALTHCARE MARKET, BY REGION 2020-2027 (USD MILLION) 51

TABLE 20 GLOBAL HOME HEALTHCARE MARKET, BY REGION 2020-2027 (USD MILLION) 52

TABLE 21 GLOBAL HOME HEALTHCARE MARKET, BY REGION 2020-2027 (USD MILLION) 54

TABLE 22 AMERICAS HOME HEALTHCARE MARKET, BY REGION 2020-2027 (USD MILLION) 56

TABLE 23 NORTH AMERICA HOME HEALTHCARE MARKET, BY COUNTRY 2020-2027 (USD MILLION) 56

TABLE 24 AMERICAS HOME HEALTHCARE MARKET, BY PRODUCT 2020-2027 (USD MILLION) 57

TABLE 25 AMERICAS HOME HEALTHCARE MARKET, BY TESTING, SCREENING, & MONITORING PRODUCTS 2020-2027 (USD MILLION) 57

TABLE 26 AMERICAS HOME HEALTHCARE MARKET, BY THERAPEUTIC PRODUCTS 2020-2027 (USD MILLION) 58

TABLE 27 AMERICAS HOME HEALTHCARE MARKET, BY SERVICES 2020-2027 (USD MILLION) 58

TABLE 28 AMERICAS HOME HEALTHCARE MARKET, BY SOFTWARE 2020-2027 (USD MILLION) 59

TABLE 29 NORTH AMERICA HOME HEALTHCARE MARKET, BY PRODUCT 2020-2027 (USD MILLION) 59

TABLE 30 NORTH AMERICA HOME HEALTHCARE MARKET, BY TESTING, SCREENING, & MONITORING PRODUCTS 2020-2027 (USD MILLION) 60

TABLE 31 NORTH AMERICA HOME HEALTHCARE MARKET, BY THERAPEUTIC PRODUCTS 2020-2027 (USD MILLION) 60

TABLE 32 NORTH AMERICA HOME HEALTHCARE MARKET, BY SERVICES 2020-2027 (USD MILLION) 61

TABLE 33 NORTH AMERICA HOME HEALTHCARE MARKET, BY SOFTWARE 2020-2027 (USD MILLION) 61

TABLE 34 U.S. HOME HEALTHCARE MARKET, BY PRODUCT 2020-2027 (USD MILLION) 61

TABLE 35 U.S. HOME HEALTHCARE MARKET, BY TESTING, SCREENING, & MONITORING PRODUCTS 2020-2027 (USD MILLION) 62

TABLE 36 U.S. HOME HEALTHCARE MARKET, BY THERAPEUTIC PRODUCTS 2020-2027 (USD MILLION) 62

TABLE 37 U.S. HOME HEALTHCARE MARKET, BY SERVICES 2020-2027 (USD MILLION) 63

TABLE 38 U.S. HOME HEALTHCARE MARKET, BY SOFTWARE 2020-2027 (USD MILLION) 63

TABLE 39 CANADA HOME HEALTHCARE MARKET, BY PRODUCT 2020-2027 (USD MILLION) 63

TABLE 40 CANADA HOME HEALTHCARE MARKET, BY TESTING, SCREENING, & MONITORING PRODUCTS 2020-2027 (USD MILLION) 64

TABLE 41 CANADA HOME HEALTHCARE MARKET, BY THERAPEUTIC PRODUCTS, 2020-2027 (USD MILLION) 64

TABLE 42 CANADA HOME HEALTHCARE MARKET, BY SERVICES, 2020-2027 (USD MILLION) 65

TABLE 43 CANADA HOME HEALTHCARE MARKET, BY SOFTWARE, 2020-2027 (USD MILLION) 65

TABLE 44 SOUTH AMERICA HOME HEALTHCARE MARKET, BY PRODUCT 2020-2027 (USD MILLION) 65

TABLE 45 SOUTH AMERICA HOME HEALTHCARE MARKET, BY TESTING, SCREENING, & MONITORING PRODUCTS 2020-2027 (USD MILLION) 66

TABLE 46 SOUTH AMERICA HOME HEALTHCARE MARKET, BY THERAPEUTIC PRODUCTS 2020-2027 (USD MILLION) 66

TABLE 47 SOUTH AMERICA HOME HEALTHCARE MARKET, BY SERVICES 2020-2027 (USD MILLION) 67

TABLE 48 SOUTH AMERICA HOME HEALTHCARE MARKET, BY SOFTWARE 2020-2027 (USD MILLION) 67

TABLE 49 EUROPE HOME HEALTHCARE MARKET, BY REGION 2020-2027 (USD MILLION) 69

TABLE 50 WESTERN EUROPE HOME HEALTHCARE MARKET, BY COUNTRY 2020-2027 (USD MILLION) 69

TABLE 51 EUROPE HOME HEALTHCARE MARKET, BY PRODUCT 2020-2027 (USD MILLION) 70

TABLE 52 EUROPE HOME HEALTHCARE MARKET, BY TESTING, SCREENING, & MONITORING PRODUCTS 2020-2027 (USD MILLION) 70

TABLE 53 EUROPE HOME HEALTHCARE MARKET, BY THERAPEUTIC PRODUCTS 2020-2027 (USD MILLION) 71

TABLE 54 EUROPE HOME HEALTHCARE MARKET, BY SERVICES 2020-2027 (USD MILLION) 71

TABLE 55 EUROPE HOME HEALTHCARE MARKET, BY SOFTWARE 2020-2027 (USD MILLION) 72

TABLE 56 WESTERN EUROPE HOME HEALTHCARE MARKET, BY PRODUCT 2020-2027 (USD MILLION) 72

TABLE 57 WESTERN EUROPE HOME HEALTHCARE MARKET, BY TESTING, SCREENING, & MONITORING PRODUCTS 2020-2027 (USD MILLION) 73

TABLE 58 WESTERN EUROPE HOME HEALTHCARE MARKET, BY THERAPEUTIC PRODUCTS 2020-2027 (USD MILLION) 73

TABLE 59 WESTERN EUROPE HOME HEALTHCARE MARKET, BY SERVICES 2020-2027 (USD MILLION) 74

TABLE 60 WESTERN EUROPE HOME HEALTHCARE MARKET, BY SOFTWARE 2020-2027 (USD MILLION) 74

TABLE 61 GERMANY HOME HEALTHCARE MARKET, BY PRODUCT 2020-2027 (USD MILLION) 74

TABLE 62 GERMANY HOME HEALTHCARE MARKET, BY TESTING, SCREENING, & MONITORING PRODUCTS 2020-2027 (USD MILLION) 75

TABLE 63 GERMANY HOME HEALTHCARE MARKET, BY THERAPEUTIC PRODUCTS 2020-2027 (USD MILLION) 75

TABLE 64 GERMANY HOME HEALTHCARE MARKET, BY SERVICES 2020-2027 (USD MILLION) 76

TABLE 65 GERMANY HOME HEALTHCARE MARKET, BY SOFTWARE 2020-2027 (USD MILLION) 76

TABLE 66 FRANCE HOME HEALTHCARE MARKET, BY PRODUCT 2020-2027 (USD MILLION) 77

TABLE 67 FRANCE HOME HEALTHCARE MARKET, BY TESTING, SCREENING, & MONITORING PRODUCTS 2020-2027 (USD MILLION) 77

TABLE 68 FRANCE HOME HEALTHCARE MARKET, BY THERAPEUTIC PRODUCTS 2020-2027 (USD MILLION) 78

TABLE 69 FRANCE HOME HEALTHCARE MARKET, BY SERVICES 2020-2027 (USD MILLION) 78

TABLE 70 FRANCE HOME HEALTHCARE MARKET, BY SOFTWARE 2020-2027 (USD MILLION) 79

TABLE 71 U.K. HOME HEALTHCARE MARKET, BY PRODUCT 2020-2027 (USD MILLION) 79

TABLE 72 U.K. HOME HEALTHCARE MARKET, BY TESTING, SCREENING, & MONITORING PRODUCTS 2020-2027 (USD MILLION) 79

TABLE 73 U.K. HOME HEALTHCARE MARKET, BY THERAPEUTIC PRODUCTS 2020-2027 (USD MILLION) 80

TABLE 74 U.K. HOME HEALTHCARE MARKET, BY SERVICES 2020-2027 (USD MILLION) 80

TABLE 75 U.K. HOME HEALTHCARE MARKET, BY SOFTWARE 2020-2027 (USD MILLION) 81

TABLE 76 ITALY HOME HEALTHCARE MARKET, BY PRODUCT 2020-2027 (USD MILLION) 81

TABLE 77 ITALY HOME HEALTHCARE MARKET, BY TESTING, SCREENING, & MONITORING PRODUCTS 2020-2027 (USD MILLION) 81

TABLE 78 ITALY HOME HEALTHCARE MARKET, BY THERAPEUTIC PRODUCTS 2020-2027 (USD MILLION) 82

TABLE 79 ITALY HOME HEALTHCARE MARKET, BY SERVICES 2020-2027 (USD MILLION) 82

TABLE 80 ITALY HOME HEALTHCARE MARKET, BY SOFTWARE 2020-2027 (USD MILLION) 83

TABLE 81 SPAIN HOME HEALTHCARE MARKET, BY PRODUCT 2020-2027 (USD MILLION) 83

TABLE 82 SPAIN HOME HEALTHCARE MARKET, BY TESTING, SCREENING, & MONITORING PRODUCTS 2020-2027 (USD MILLION) 83

TABLE 83 SPAIN HOME HEALTHCARE MARKET, BY THERAPEUTIC PRODUCTS 2020-2027 (USD MILLION) 84

TABLE 84 SPAIN HOME HEALTHCARE MARKET, BY SERVICES 2020-2027 (USD MILLION) 84

TABLE 85 SPAIN HOME HEALTHCARE MARKET, BY SOFTWARE 2020-2027 (USD MILLION) 85

TABLE 86 REST OF WESTERN EUROPE HOME HEALTHCARE MARKET, BY PRODUCT 2020-2027 (USD MILLION) 85

TABLE 87 REST OF WESTERN EUROPE HOME HEALTHCARE MARKET, BY TESTING, SCREENING, & MONITORING PRODUCTS 2020-2027 (USD MILLION) 85

TABLE 88 REST OF WESTERN EUROPE HOME HEALTHCARE MARKET, BY THERAPEUTIC PRODUCTS 2020-2027 (USD MILLION) 86

TABLE 89 REST OF WESTERN EUROPE HOME HEALTHCARE MARKET, BY SERVICES 2020-2027 (USD MILLION) 86

TABLE 90 REST OF WESTERN EUROPE HOME HEALTHCARE MARKET, BY SOFTWARE 2020-2027 (USD MILLION) 87

TABLE 91 EASTERN EUROPE HOME HEALTHCARE MARKET, BY PRODUCT 2020-2027 (USD MILLION) 87

TABLE 92 EASTERN EUROPE HOME HEALTHCARE MARKET, BY TESTING, SCREENING, & MONITORING PRODUCTS 2020-2027 (USD MILLION) 88

TABLE 93 EASTERN EUROPE HOME HEALTHCARE MARKET, BY THERAPEUTIC PRODUCTS 2020-2027 (USD MILLION) 88

TABLE 94 EASTERN EUROPE HOME HEALTHCARE MARKET, BY SERVICES 2020-2027 (USD MILLION) 89

TABLE 95 EASTERN EUROPE HOME HEALTHCARE MARKET, BY SOFTWARE 2020-2027 (USD MILLION) 89

TABLE 96 ASIA-PACIFIC HOME HEALTHCARE MARKET, BY COUNTRY 2020-2027 (USD MILLION) 91

TABLE 97 ASIA-PACIFIC HOME HEALTHCARE MARKET, BY PRODUCT 2020-2027 (USD MILLION) 92

TABLE 98 ASIA-PACIFIC HOME HEALTHCARE MARKET, BY TESTING, SCREENING, & MONITORING PRODUCTS 2020-2027 (USD MILLION) 92

TABLE 99 ASIA-PACIFIC HOME HEALTHCARE MARKET, BY THERAPEUTIC PRODUCTS 2020-2027 (USD MILLION) 93

TABLE 100 ASIA-PACIFIC HOME HEALTHCARE MARKET, BY SERVICES 2020-2027 (USD MILLION) 93

TABLE 101 ASIA-PACIFIC HOME HEALTHCARE MARKET, BY SOFTWARE 2020-2027 (USD MILLION) 94

TABLE 102 JAPAN HOME HEALTHCARE MARKET, BY PRODUCT 2020-2027 (USD MILLION) 94

TABLE 103 JAPAN HOME HEALTHCARE MARKET, BY TESTING, SCREENING, & MONITORING PRODUCTS 2020-2027 (USD MILLION) 94

TABLE 104 JAPAN HOME HEALTHCARE MARKET, BY THERAPEUTIC PRODUCTS 2020-2027 (USD MILLION) 95

TABLE 105 JAPAN HOME HEALTHCARE MARKET, BY SERVICES 2020-2027 (USD MILLION) 95

TABLE 106 JAPAN HOME HEALTHCARE MARKET, BY SOFTWARE 2020-2027 (USD MILLION) 96

TABLE 107 CHINA HOME HEALTHCARE MARKET, BY PRODUCT 2020-2027 (USD MILLION) 96

TABLE 108 CHINA HOME HEALTHCARE MARKET, BY TESTING, SCREENING, & MONITORING PRODUCTS 2020-2027 (USD MILLION) 96

TABLE 109 CHINA HOME HEALTHCARE MARKET, BY THERAPEUTIC PRODUCTS 2020-2027 (USD MILLION) 97

TABLE 110 CHINA HOME HEALTHCARE MARKET, BY SERVICES 2020-2027 (USD MILLION) 97

TABLE 111 CHINA HOME HEALTHCARE MARKET, BY SOFTWARE 2020-2027 (USD MILLION) 98

TABLE 112 INDIA HOME HEALTHCARE MARKET, BY PRODUCT 2020-2027 (USD MILLION) 98

TABLE 113 INDIA HOME HEALTHCARE MARKET, BY TESTING, SCREENING, & MONITORING PRODUCTS 2020-2027 (USD MILLION) 98

TABLE 114 INDIA HOME HEALTHCARE MARKET, BY THERAPEUTIC PRODUCTS 2020-2027 (USD MILLION) 99

TABLE 115 INDIA HOME HEALTHCARE MARKET, BY SERVICES 2020-2027 (USD MILLION) 99

TABLE 116 INDIA HOME HEALTHCARE MARKET, BY SOFTWARE 2020-2027 (USD MILLION) 100

TABLE 117 REPUBLIC OF KOREA HOME HEALTHCARE MARKET, BY PRODUCT 2020-2027 (USD MILLION) 100

TABLE 118 REPUBLIC OF KOREA HOME HEALTHCARE MARKET, BY TESTING, SCREENING, & MONITORING PRODUCTS 2020-2027 (USD MILLION) 101

TABLE 119 REPUBLIC OF KOREA HOME HEALTHCARE MARKET, BY THERAPEUTIC PRODUCTS 2020-2027 (USD MILLION) 101

TABLE 120 REPUBLIC OF KOREA HOME HEALTHCARE MARKET, BY SERVICES 2020-2027 (USD MILLION) 102

TABLE 121 REPUBLIC OF KOREA HOME HEALTHCARE MARKET, BY SOFTWARE 2020-2027 (USD MILLION) 102

TABLE 122 AUSTRALIA HOME HEALTHCARE MARKET, BY PRODUCT 2020-2027 (USD MILLION) 102

TABLE 123 AUSTRALIA HOME HEALTHCARE MARKET, BY TESTING, SCREENING, & MONITORING PRODUCTS 2020-2027 (USD MILLION) 103

TABLE 124 AUSTRALIA HOME HEALTHCARE MARKET, BY THERAPEUTIC PRODUCTS 2020-2027 (USD MILLION) 103

TABLE 125 AUSTRALIA HOME HEALTHCARE MARKET, BY SERVICES 2020-2027 (USD MILLION) 104

TABLE 126 AUSTRALIA HOME HEALTHCARE MARKET, BY SOFTWARE 2020-2027 (USD MILLION) 104

TABLE 127 REST OF ASIA-PACIFIC HOME HEALTHCARE MARKET, BY PRODUCT 2020-2027 (USD MILLION) 104

TABLE 128 REST OF ASIA-PACIFIC HOME HEALTHCARE MARKET, BY TESTING, SCREENING, & MONITORING PRODUCTS 2020-2027 (USD MILLION) 105

TABLE 129 REST OF ASIA-PACIFIC HOME HEALTHCARE MARKET, BY THERAPEUTIC PRODUCTS 2020-2027 (USD MILLION) 105

TABLE 130 REST OF ASIA-PACIFIC HOME HEALTHCARE MARKET, BY SERVICES 2020-2027 (USD MILLION) 106

TABLE 131 REST OF ASIA-PACIFIC HOME HEALTHCARE MARKET, BY SOFTWARE 2020-2027 (USD MILLION) 106

TABLE 132 MIDDLE EAST & AFRICA HOME HEALTHCARE MARKET, BY COUNTRY 2020-2027 (USD MILLION) 108

TABLE 133 MIDDLE EAST & AFRICA HOME HEALTHCARE MARKET, BY PRODUCT 2020-2027 (USD MILLION) 108

TABLE 134 MIDDLE EAST & AFRICA HOME HEALTHCARE MARKET, BY TESTING, SCREENING, & MONITORING PRODUCTS 2020-2027 (USD MILLION) 109

TABLE 135 MIDDLE EAST & AFRICA HOME HEALTHCARE MARKET, BY THERAPEUTIC PRODUCTS 2020-2027 (USD MILLION) 109

TABLE 136 MIDDLE EAST & AFRICA HOME HEALTHCARE MARKET, BY SERVICES 2020-2027 (USD MILLION) 110

TABLE 137 MIDDLE EAST & AFRICA HOME HEALTHCARE MARKET, BY SOFTWARE 2020-2027 (USD MILLION) 110

TABLE 138 UNITED ARAB EMIRATES HOME HEALTHCARE MARKET, BY PRODUCT 2020-2027 (USD MILLION) 110

TABLE 139 UNITED ARAB EMIRATES HOME HEALTHCARE MARKET, BY TESTING, SCREENING, & MONITORING PRODUCTS 2020-2027 (USD MILLION) 111

TABLE 140 UNITED ARAB EMIRATES HOME HEALTHCARE MARKET, BY THERAPEUTIC PRODUCTS 2020-2027 (USD MILLION) 111

TABLE 141 UNITED ARAB EMIRATES HOME HEALTHCARE MARKET, BY SERVICES 2020-2027 (USD MILLION) 112

TABLE 142 UNITED ARAB EMIRATES HOME HEALTHCARE MARKET, BY SOFTWARE 2020-2027 (USD MILLION) 112

TABLE 143 SAUDI ARABIA HOME HEALTHCARE MARKET, BY PRODUCT 2020-2027 (USD MILLION) 112

TABLE 144 SAUDI ARABIA HOME HEALTHCARE MARKET, BY TESTING, SCREENING, & MONITORING PRODUCTS 2020-2027 (USD MILLION) 113

TABLE 145 SAUDI ARABIA HOME HEALTHCARE MARKET, BY THERAPEUTIC PRODUCTS 2020-2027 (USD MILLION) 113

TABLE 146 SAUDI ARABIA MARKET, BY SERVICES 2020-2027 (USD MILLION) 114

TABLE 147 SAUDI ARABIA HOME HEALTHCARE MARKET, BY SOFTWARE 2020-2027 (USD MILLION) 114

TABLE 148 OMAN MARKET, BY PRODUCT 2020-2027 (USD MILLION) 114

TABLE 149 OMAN HOME HEALTHCARE MARKET, BY TESTING, SCREENING, & MONITORING PRODUCTS 2020-2027 (USD MILLION) 115

TABLE 150 OMAN HOME HEALTHCARE MARKET, BY THERAPEUTIC PRODUCTS 2020-2027 (USD MILLION) 115

TABLE 151 OMAN HOME HEALTHCARE MARKET, BY SERVICES 2020-2027 (USD MILLION) 116

TABLE 152 OMAN MARKET, BY SOFTWARE 2020-2027 (USD MILLION) 116

TABLE 153 KUWAIT HOME HEALTHCARE MARKET, BY PRODUCT 2020-2027 (USD MILLION) 116

TABLE 154 KUWAIT HOME HEALTHCARE MARKET, BY TESTING, SCREENING, & MONITORING PRODUCTS 2020-2027 (USD MILLION) 117

TABLE 155 KUWAIT HOME HEALTHCARE MARKET, BY THERAPEUTIC PRODUCTS 2020-2027 (USD MILLION) 117

TABLE 156 KUWAIT MARKET, BY SERVICES 2020-2027 (USD MILLION) 118

TABLE 157 KUWAIT HOME HEALTHCARE MARKET, BY SOFTWARE 2020-2027 (USD MILLION) 118

TABLE 158 QATAR MARKET, BY PRODUCT 2020-2027 (USD MILLION) 118

TABLE 159 QATAR MARKET, BY TESTING, SCREENING, & MONITORING PRODUCTS 2020-2027 (USD MILLION) 119

TABLE 160 QATAR HOME HEALTHCARE MARKET, BY THERAPEUTIC PRODUCTS 2020-2027 (USD MILLION) 119

TABLE 161 QATAR HOME HEALTHCARE MARKET, BY SERVICES 2020-2027 (USD MILLION) 120

TABLE 162 QATAR HOME HEALTHCARE MARKET, BY SOFTWARE 2020-2027 (USD MILLION) 120

TABLE 163 REST OF MIDDLE EAST & AFRICA HOME HEALTHCARE MARKET, BY PRODUCT 2020-2027 (USD MILLION) 120

TABLE 164 REST OF MIDDLE EAST & AFRICA MARKET, BY TESTING, SCREENING, & MONITORING PRODUCTS 2020-2027 (USD MILLION) 121

TABLE 165 REST OF MIDDLE EAST & AFRICA HOME HEALTHCARE MARKET, BY THERAPEUTIC PRODUCTS 2020-2027 (USD MILLION) 121

TABLE 166 REST OF MIDDLE EAST & AFRICA HOME HEALTHCARE MARKET, BY SERVICES 2020-2027 (USD MILLION) 122

TABLE 167 REST OF MIDDLE EAST & AFRICA HOME HEALTHCARE MARKET, BY SOFTWARE 2020-2027 (USD MILLION) 122

13 List Of Figures

FIGURE 1 GLOBAL MARKET: MARKET STRUCTURE 19

FIGURE 2 KEY TAKEAWAYS OF THE MARKET 20

FIGURE 3 KEY BUYING CRITERIA OF INFLIGHT ADVERTISING 20

FIGURE 4 RESEARCH METHODOLOGY 22

FIGURE 5 GLOBAL MARKET: PORTER FIVE FORCES ANALYSIS 26

FIGURE 6 GLOBAL MARKET, BY PRODUCT, 2020 & 2027 (US$ MILLION) 41

FIGURE 7 GLOBAL MARKET, BY SERVICES, 2020 & 2027 (US$ MILLION) 45

FIGURE 8 GLOBAL MARKET, BY SOFTWARE, 2020 & 2027 (US$ MILLION) 50

FIGURE 9 GLOBAL MARKET, BY REGION, 2020 & 2027 (US$ MILLION) 54

FIGURE 10 AMERICAS MARKET, BY REGION 2020 (%) 56

FIGURE 11 EUROPE HOME HEALTHCARE MARKET, BY REGION 2020 (%) 69

FIGURE 12 ASIA-PACIFIC HOME HEALTHCARE MARKET, BY COUNTRY 2020 (%) 91

FIGURE 13 MIDDLE EAST & AFRICA MARKET, BY COUNTRY 2020 (%) 108

FIGURE 14 GLOBAL HOME HEALTHCARE MARKET, 2020 124

ホームヘルスケア市場

在宅医療市場は、2020年から2027年にかけて11.6%のCAGRで2,739億米ドルで成長しています。

セグメンテーション

By Product Therapeutic Products
By Service Skilled Nursing Services Respiratory Therapy Service
By Software Clinical Management System Telehealth Solution

キープレーヤー

  • Koninklijke Philips N.V.
  • F. Hoffmann-La Roche AG
  • A&D Company
  • Fresenius SE & Co KGaA
  • Abbott
  • GE Healthcare
  • McKesson Corporation
  • B. Braun Melsungen AG
  • Becton Dickinson Company
  • Omron Corporation
  • Medtronic PLC
  • LG Electronics
  • Kinnser Software
  • Apple
  • 3M

運転手

  • Increasing demand for home healthcare for the implication amongst the old and geriatric population
  • rising in various global locations
Speak to Analyst Request a Free Sample


在宅医療市場の概要:


在宅医療の市場規模は、2019年から2027年の進行中の予測期間中に、かなりの進歩と拡大の機会を目の当たりにしています。在宅医療市場は、進行中の予測期間における市場の運営の中で、グローバルCAGR11.6%で拡大する可能性が高い。予測期間の終わりまでに、市場は2739億米ドルの世界市場総額で評価される可能性が高い。


在宅医療市場の動向は、高齢者人口の急速な増加と慢性疾患の発生率の上昇を目の当たりにしています。これは、医療費の増加と在宅介護機器の利用可能性に関する技術の進歩により、費用対効果の高い医療提供の必要性が高まっていることは否定できない事実です。


COVID19 分析


パンデミックとして発生した新型コロナウイルス感染症の発生は、世界中の在宅医療市場の動向に重大な課題をもたらしました。世界的なパンデミックは、医療およびヘルスケアサービス分野に大きな影響を与えています。しかし、パンデミックの蔓延が巨大で憂慮すべきものであったため、世界中の比較行政への関心が拡大しました。市場の製品とサービスの利用は、拡散中にウイルスに感染した人々の形でのクライアントの維持と、市場のプレーヤー間の反対を拡大するためのものです。恒久的および一時的な封鎖のような公的機関の制限のために市場のプレーヤーと組織の機能しないことは苦しんでいます。同様に、致命的な病気の変化と拡大を減らすために、公的機関は、基本的で余分な労働と製品を供給する店の開店と閉鎖に計画と機能上の制限を強制しました。グローバル組織は苦戦しており、制限が着実に緩和された後にのみビジネスが成長し始めました。


在宅医療市場が発展するために、公的機関はこれらの行政に関する認識と情報を世界市場に広めることによって組織に焦点を合わせています。与えられたその単純さと快適さから推測できるほど、市場はおそらく、プレーヤーがアイテムの拡大、進歩、そしてその後、激しい市場競争とグローバル市場での存在感を形作るのを助ける革新的な作業部門への関心を拡大するでしょう2028年に終了する予測期間の前提。


マーケットダイナミクス


ドライバー


在宅医療市場の動向は、2028年に終了する可能性が高い進行中の予測期間中に、世界中のさまざまな場所に住み、増加している高齢者や高齢者の人口の間で、在宅医療の需要が高まっていることを示しています。高齢者は急性および慢性疾患にかかる傾向が高く、予測期間中に市場の製品やサービスの需要が高まっています。市場は、ヘルスケアサービス、デバイス、および製品の全体的なグローバルリーチとアクセスを強化することができます。また、これらの製品やサービスを利用することで、不要な通院、入院、再入院を減らすことができます。また、医療従事者に会うための移動にかかる時間とコストが削減され、その後、グローバル市場シナリオでの生産レベルが低下します。これらの要因はすべて、ホームヘルスケア市場が良好な市場レートで拡大する可能性をまとめて追加および強化する可能性があります。


拘束


在宅ケアの間、雇用されている看護師と医師の協会は対面での接触が少なく、看護師は患者の在宅ケアの評価と所見の伝達を担当します。この要因は、特に進行中の予測期間中、患者の安全性と転帰の程度に影響を与える可能性があります。これは信頼の低下につながる可能性があり、2028年に終了する進行中の予測期間中に在宅医療市場の成長を妨げる可能性があります。


テクノロジー分析


在宅医療は、北米とヨーロッパ諸国の先進地域における主要な傾向です。これらの地域では優勢な規制と政策が好調であるため、在宅医療は急速に大規模に採用されています。先進国の市場がほぼ飽和状態にあるため、著名な市場プレーヤーは、開発途上地域、特にアジア太平洋地域の発展途上経済に焦点を移しています。のコンセプトとして インドや中国などの国の在宅医療はまだ初期段階にあり、在宅医療市場のプレーヤーはこれらの未開拓の市場で幅広い機会を活用できます。


研究目標



  • 市場レポートは、パンデミックの前、最中、および後の市場の動作を調査し、パンデミックの影響を理解することを目的としています。また、レポートは、2028年に終了する現在の予測期間中に予想される在宅医療市場の予想される発展を妨げている要因を調査しています。

  • 市場レポートは、市場をさまざまなセグメントに分割し、在宅医療市場の利用を莫大な範囲で要求している世界の重要な地質における彼らの仕事と有用性を理解することにより、利用可能な作業を集中させることを目的としています

  • このレポートは、実際的な地域に依存する市場の分岐を理解することを目的としています。さらに、レポートは、2017-2028の進行中の予測期間中に世界市場に蔓延している深刻な程度を理解することを計画しています。競争を研究することにより、市場は世界規模で彼らの新しい出来事に気づくことによって世界中のプレーヤーの間で真剣な比較を描くことを計画しています。


セグメントの概要


在宅医療の市場シェアは、業界の専門家による期間の予測に基づいて、期間中の市場の世界的な拡大に役立つ一連の要因に基づいて分割されています。市場セグメントは次のように説明されています


市場製品に基づく


在宅医療市場は細分化されており、テスト、スクリーニング、モニタリング製品、血糖モニター、血圧モニター、パルスオキシメーター、ピークフローメーター、心拍数モニター、胎児モニタリングデバイス、HIVテストキット、家庭用睡眠テストデバイスなどが含まれます。松葉杖など。


市場サービスに基づく


市場のサービスセグメントには、熟練看護サービス、リハビリテーション療法サービス、ホスピス、緩和ケアサービス、非熟練ケアサービス、呼吸療法サービス、輸液療法サービス、および妊娠ケアサービスなどのその他が含まれます


表示に基づく


市場は細分化されており、心血管障害と高血圧、糖尿病、呼吸器疾患、妊娠、運動障害、聴覚障害、がん、創傷ケア、および睡眠障害、腎臓障害、神経血管疾患、HIVなどの他の適応症が含まれています。


地域分析


北米地域は、在宅医療の需要の高まりと在宅医療の治療を提供する診療所や病院の増加により、在宅医療の市場で第1の地位を維持すると予測されています。アメリカでは、北米市場は、在宅医療用の製品と機器の両方を提供する主要な市場プレーヤーが存在するため、最大の市場です。


競争環境


在宅医療市場の動向は、次のような市場関係者のため、競争が激化しています。


最近の動向



  • 市場は、市場の未開拓地域と発展途上地域で機能を拡大しています。2017年4月、著名な市場プレーヤーの1つであるQuadria Capital(シンガポール)は、Dabur家族経営のHealthcare at Home(HCAH)に約4000万米ドル(250インドルピー)を投資しました。

  • 2020年、リンデの子会社であるリンケアは、米国で在宅呼吸ケアを提供しました。COVID-19のパンデミックに対応して、同社はCOVID-19の脆弱な患者に在宅サービスを提供してきました。

  • 別の市場プレーヤーであるLHC Group Inc(米国)は、ユニバーシティヘルスケアシステム(米国)と合弁契約を締結しました。この背後にある考え方は、在宅医療とホスピスサービスを強化することです。


対象読者



  • 医療およびヘルスケアのディーラー、生産者、および製造業者

  • ヘルスケア機器の材料と資源のサプライヤー

  • 研究会社と研究所

  • ヘルスケア IT グループと企業

  • 研究開発 (R&D) 企業

  • 市場調査およびコンサルティングサービスディーラーおよびサービスプロバイダー



    Report Scope:
    Report Attribute/Metric Details
      Market Size   USD 273.9 Billion
      CAGR   6.3%
      Base Year   2021
      Forecast Period   2022-2030
      Historical Data   2020
      Forecast Units    Value (USD Billion)
      Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
      Segments Covered   Product, Service, Software
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   Koninklijke Philips N.V. (The Netherlands), F. Hoffmann-La Roche AG (Switzerland), A&D Company (Japan), Fresenius SE & Co KGaA (Germany), Abbott (U.S.), GE Healthcare (U.S.), McKesson Corporation (U.S.), B. Braun Melsungen AG (Germany), Becton Dickinson Company (U.S.), Omron Corporation (Japan), Medtronic PLC (U.S.), LG Electronics (South Korea), Kinnser Software (U.S.), Apple (U.S.), 3M (U.S.), and others.
      Key Market Opportunities   New product launches and R&D Amongst major key Players
      Key Market Drivers

  • Technological advances in healthcare and diagnosis equipment
  • Government initiatives


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    Home healthcare is a cost-effective solution perfect for many to recuperate after their initial treatment in a hospital. It can also be beneficial for those who find it difficult to move. According to the National Association for Home Care & Hospice, home healthcare for 60 days costs around USD 2,700 whereas, for that same duration, hospital costs around USD 8,500. Quite clearly, home healthcare has the benefits hands down.

    Home Healthcare Market Information by Product (Therapeutic products, Other), Service (Skilled Nursing Services, Respiratory Therapy Service, Other), Software (Clinical Management System, Telehealth Solution, Other) – Forecast till 2030

    The home healthcare market is anticipated to reach USD 568 Billion by 2030. The global market’s North American region covers markets across the United States, Mexico, Canada, and others.

    The Home Healthcare Market is expected to exhibit a CAGR of 6.3% from 2022 to 2030

    The growing geriatric population and rise in healthcare expenses are major drivers of the Home Healthcare Market.

    Medtronic PLC, F. Hoffmann-La Roche AG, B. Braun Melsungen AG, LG Electronics, Becton Dickinson Company, 3M, Fresenius SE & Co KGaA, Koninklijke Philips N.V., Abbott, Kinnser Software, Omron Corporation, GE Healthcare, McKesson Corporation, A&D Company, and Apple are the major players in the home healthcare market.

    Concerns among patients regarding their data is the biggest restraint of the home healthcare market.

Global Home Healthcare Market: Competitive Landscape


The global home healthcare is currently dominated by many market players such as Philips Healthcare (Netherlands), Kindred Healthcare (US), Linde Group (Germany), Almost Family Inc. (US), Abbott Laboratories (US), and others.  


Koninklijke Philips N.V. accounted for a major share (21.3%) of the global home healthcare market due to the increasing demand for home healthcare devices worldwide. Additionally, this company has a strong sales and distribution network as well as it provides after sales services and support, which play a major role in customers’ satisfaction. Additionally, the company is engaged in strategic collaborations and mergers which helps the company to hold its market position. For instance, in August 2016, Koninklijke Philips N.V. and Qualcomm signed a strategic collaboration to advance personalized connected healthcare.

Hoffmann-La Roche AG was the second largest in terms of market share, in 2016. F. Hoffmann-La Roche AG accounted for approximately 19.7%, which can be attributed to its product, the ‘ACCU-CHEK,’ which is one of the safety lancets having high demand in both developed and developing regions.


Abbott Laboratories acquired the third largest spot in the market. The company has a strategy of delivering integrated solutions to large healthcare customers and increasing its product portfolio which helps the company in maintaining its market position. Additionally, the company is engaged in strategic acquisitions and collaborations which strengthens its position and expand its market presence globally. For instance, in January 2017, the company acquired St. Jude Medical to strengthen its medical device leadership with innovations in cardiovascular and neuromodulation.


Medtronic PLC is the fourth largest owing to its strategy of launching new products and increasing R&D investments to improve the quality of the product. Additionally, the company is focused on acquisitions to strengthen its market presence in the global market. For instance, in August 2016, the company completed the acquisition of HeartWare International, Inc., a leading innovator of less invasive, miniaturized, Mechanical Circulatory Support (MCS) technologies for treating patients with heart failure.


The home healthcare products and services are developed by different domain players such as device manufacturers (medical, wearable, and others), mobile operators, content providers, healthcare providers, and pharmaceutical and medical insurers. The growing demand for these solutions owing to their convenience, accuracy, and cost-effectiveness have led the companies to increase the focus on new product developments and innovations. In the global home healthcare market, major companies are opting for strategic partnerships and collaborations to strengthen their market position.